Manufacturing News and Research

RSS

Manufacturing is the production of products across all industries, on a large-scale, using machinery.

Dartmouth, Aeras to jointly conduct trial of DAR-901 vaccine against TB

Dartmouth's Geisel School of Medicine and Aeras, a global nonprofit biotech, announced a collaboration to jointly conduct a trial of a new vaccine against tuberculosis (TB), one of the world's deadliest diseases. The vaccine, known as DAR-901, is related to the vaccine SRL-172, previously shown by Dartmouth investigators to decrease the risk of TB in a trial known as the DarDar Trial.

19 Mar 2014

Chemical engineers design way to manufacture peptides in mere hours

Small protein fragments, also called peptides, are promising as drugs because they can be designed for very specific functions inside living cells. Insulin and the HIV drug Fuzeon are some of the earliest successful examples, and peptide drugs are expected to become a $25 billion market by 2018.

19 Mar 2014

New invention helps body generate new bone which is as strong as original

Periodontitis can cause teeth to come loose. Mandibular cancer can disfigure a face. With the aid of artificial, foam-rubber-shaped scaffolding, the body can be helped to repair the damage by itself.

19 Mar 2014

Ironwood Pharmaceuticals starts Phase IIa clinical study of IW-3718 for gastroesophageal reflux disease

Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) announced today that dosing has begun in its Phase IIa clinical study of its investigational compound IW-3718 in patients suffering from gastroesophageal reflux disease (GERD) who have not responded adequately to treatment with a proton pump inhibitor (PPI). Data are expected in the first half of 2015.

18 Mar 2014

Sparton completes all-cash transaction to acquire Aubrey Group

Sparton Corporation announces that it completed an all-cash transaction to acquire Aubrey Group, Inc., an $8 million revenue business, on March 17, 2014. Aubrey will continue to service its current and future customers out of its Irvine, CA location.

18 Mar 2014

ChromaTrap™ Chromatin Immunoprecipitation technology receives positive commentary in published paper

Porvair Sciences reports on positive commentary by researchers in published papers citing how using the fast, sensitive ChromaTrap™ Chromatin Immunoprecipitation (ChIP) technology has benefited their research.

From Chromatrap® - Porvair Sciences Ltd 18 Mar 2014

Loyola urogynecologist receives 2014 Christina Manthos Mentoring Award from SWIU

Elizabeth Mueller, MD, MS, has been named a 2014 Christina Manthos Mentoring Award recipient by the Society of Women in Urology (SWIU). Dr. Mueller is the division director and the fellowship program director of Female Pelvic Medicine & Reconstructive Surgery at Loyola University Health System.

18 Mar 2014

Yongye’s revenue increases 49.4% to $661.9M in fourth quarter 2013

Yongye International, Inc.("Yongye" or the "Company"), a leading developer, manufacturer, and distributor of crop nutrient products in the People's Republic of China ("PRC"), today announced its financial results for the fourth quarter and full year ended December 31, 2013.

17 Mar 2014

Self-assembling DNA cages hold potential promise in drug delivery

Move over, nanotechnologists, and make room for the biggest of the small. Scientists at the Harvard's Wyss Institute have built a set of self-assembling DNA cages one-tenth as wide as a bacterium.

17 Mar 2014

Venaxis' APPY1 Test for appendicitis shows positive results in pivotal U.S. study

Venaxis, Inc., an in vitro diagnostic company focused on obtaining FDA clearance for and commercializing its CE Marked APPY1 Test, a rapid, multiple biomarker-based assay for identifying patients that are at low risk for appendicitis, today announced positive top-line results from its pivotal U.S. study.

14 Mar 2014

Antares Pharma reports total revenue of $4.7 million for fourth quarter 2013

Antares Pharma, Inc. today reported operating and financial results for the fourth quarter and full year ended December 31, 2013.

13 Mar 2014

AnaptysBio announces strategic immuno-oncology collaboration with TESARO

AnaptysBio, Inc., a leader in the discovery and development of therapeutic antibodies, today announced a strategic immuno-oncology collaboration with TESARO, Inc., an oncology-focused biopharmaceutical company.

13 Mar 2014

Aradigm reports record revenue of $4.6M in fourth quarter 2013

Aradigm Corporation (the "Company") today announced financial results for the fourth quarter and full year ended December 31, 2013.

13 Mar 2014

Notre Dame biologists awarded $23M research grant to prevent malaria and dengue fever

Notre Dame biologists Nicole Achee and Neil Lobo are leaders of an international $23 million research grant from the Bill & Melinda Gates Foundation. Their five-year project will generate the data required to show the effectiveness of a new paradigm in mosquito control -spatial repellency - for the prevention of two important mosquito-borne diseases: malaria and dengue fever.

13 Mar 2014

Hi-Tech Pharmacal's third fiscal quarter net sales decrease 7% to $59.9 million

Hi-Tech Pharmacal Co., Inc. today reported results for the third fiscal quarter ended January 31, 2014.

11 Mar 2014

Proteus Digital Health teams up with leading organisations to bring digital health technology to the UK

Leading digital medicines company Proteus Digital Health is partnering with Eastern Academic Health Science Network, The Northern Health Science Alliance and Oxford University, Oxford University Hospitals NHS Trust and Oxford Academic Health Science Network to bring digital health technology and global operations and manufacturing to the UK.

10 Mar 2014

UOC ventures into U.S. market to offer safe, cost-effective hip and knee devices

Today, United Orthopedic Corporation (UOC) - a leading international designer, manufacturer, and distributor of innovative orthopedic implants and instruments - announced its entrance into the American market, offering clinically proven, safe and cost-effective hip and knee devices through its U.S. subsidiary, UOC USA.

7 Mar 2014

Nordion generates $70.8 million in revenue for first quarter of fiscal 2014

Nordion Inc., a leading provider of products and services to the global health science market, today reported results for the first quarter of fiscal 2014.

7 Mar 2014

Biodegradable scaffolds promote tissue growth during the healing process

Researchers from the University of Pittsburgh's Swanson School of Engineering and McGowan Institute for Regenerative Medicine (MIRM) are proposing that if 3-D printers, or additive manufacturing, can produce custom replacement parts for machines, why couldn't the same process create biodegradable tissue repair structures for the human body?

7 Mar 2014

Tetraphase Pharmaceuticals reports net loss of $11.3 million for Q4 2013

Tetraphase Pharmaceuticals, Inc. today reported financial results for the quarter and full year ended December 31, 2013.

6 Mar 2014

Manufacturing News and Research

Further Reading

Dartmouth, Aeras to jointly conduct trial of DAR-901 vaccine against TB

Chemical engineers design way to manufacture peptides in mere hours

New invention helps body generate new bone which is as strong as original

Ironwood Pharmaceuticals starts Phase IIa clinical study of IW-3718 for gastroesophageal reflux disease

Sparton completes all-cash transaction to acquire Aubrey Group

ChromaTrap™ Chromatin Immunoprecipitation technology receives positive commentary in published paper

Loyola urogynecologist receives 2014 Christina Manthos Mentoring Award from SWIU

Yongye’s revenue increases 49.4% to $661.9M in fourth quarter 2013

Self-assembling DNA cages hold potential promise in drug delivery

Venaxis' APPY1 Test for appendicitis shows positive results in pivotal U.S. study

Antares Pharma reports total revenue of $4.7 million for fourth quarter 2013

AnaptysBio announces strategic immuno-oncology collaboration with TESARO

Aradigm reports record revenue of $4.6M in fourth quarter 2013

Notre Dame biologists awarded $23M research grant to prevent malaria and dengue fever

Hi-Tech Pharmacal's third fiscal quarter net sales decrease 7% to $59.9 million

Proteus Digital Health teams up with leading organisations to bring digital health technology to the UK

UOC ventures into U.S. market to offer safe, cost-effective hip and knee devices

Nordion generates $70.8 million in revenue for first quarter of fiscal 2014

Biodegradable scaffolds promote tissue growth during the healing process

Tetraphase Pharmaceuticals reports net loss of $11.3 million for Q4 2013

Exploring the G:Box and for high-quality imaging

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Latest Life Science News